Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,396,924,218
+$4,700,056 QoQ
Shares Held
12,640,672
+4.2% QoQ
Ownership
0.815%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#17
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. AZN ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,396,924,218 | 12,640,672 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $2,392,224,162 | 12,129,724 | Shares | Defined | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||